Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-23
2006-05-23
Davis, Zinna Northington (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S210010, C514S252130, C514S422000, C514S423000, C544S359000, C546S139000, C548S517000, C548S518000
Reexamination Certificate
active
07049323
ABSTRACT:
Novel azetidinyl and pyrrolidinyl compounds are ligands of melanocortin-4 receptors and are useful for treating conditions responsive to the modulation of melanocortin-4 receptors such as obesity, diabetes, and sexual dysfunction.
REFERENCES:
patent: WO 99/64002 (1999-12-01), None
patent: WO 00/74679 (2000-12-01), None
patent: WO 01/70337 (2001-09-01), None
patent: WO 01/70708 (2001-09-01), None
patent: WO 01/91752 (2001-12-01), None
patent: WO 02/15909 (2002-02-01), None
patent: WO 02/066869 (2002-08-01), None
patent: WO 02/068387 (2002-09-01), None
patent: WO 02/068388 (2002-09-01), None
patent: WO 02/070511 (2002-09-01), None
patent: WO 02/079146 (2002-10-01), None
patent: WO 03/007949 (2003-01-01), None
Beno Brett R.
Chaturvedula Prasad V.
Luo Guanglin
Poindexter Graham S.
Vig Shikha
Bristol--Myers Squibb Company
Davis Zinna Northington
Epperson James
LandOfFree
Amidoheterocycles as modulators of the melanocortin-4 receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amidoheterocycles as modulators of the melanocortin-4 receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amidoheterocycles as modulators of the melanocortin-4 receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3580823